Clinicopathological characteristics associated with necrosis in pulmonary metastases from colorectal cancer.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
May 2019
Historique:
received: 02 11 2018
accepted: 28 01 2019
revised: 23 01 2019
pubmed: 15 2 2019
medline: 17 5 2019
entrez: 15 2 2019
Statut: ppublish

Résumé

Metastatic lung cancers from the colon and rectum (MLCR) frequently have necrotic components. The aim of this study is to elucidate clinicopathological factors associated with the amount of necrosis in MLCR. Ninety patients who underwent the first pulmonary metastasectomy for MLCR with a tumor diameter ≦ 3.0 cm and without chemotherapy were enrolled in this study. Analyzing digitally scanned pathological slides, we calculated the necrosis percentage (NP, the necrosis area divided by the tumor area). The relationship between NP and clinicopathological factors was analyzed. Moreover, to determine whether NP was affected by tissue hypoxia, vascularization, or tumor cell proliferation, tissues were analyzed by immunohistochemical staining using carbonic anhydrase IX (CAIX), CD34 antibodies, and Ki-67 antibodies, respectively. Median tumor area and NP were 0.69 cm

Identifiants

pubmed: 30762121
doi: 10.1007/s00428-019-02535-7
pii: 10.1007/s00428-019-02535-7
doi:

Substances chimiques

Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-575

Auteurs

Jun Suzuki (J)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Motohiro Kojima (M)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Keiju Aokage (K)

Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Takashi Sakai (T)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Hiroshi Nakamura (H)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Yuuki Ohara (Y)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.

Kenta Tane (K)

Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Tomohiro Miyoshi (T)

Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Masato Sugano (M)

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.

Satoshi Fujii (S)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Takeshi Kuwata (T)

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.

Atsushi Ochiai (A)

Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.

Masaaki Ito (M)

Department of Colorectal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

Kenji Suzuki (K)

Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Masahiro Tsuboi (M)

Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Genichiro Ishii (G)

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. gishii@east.ncc.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH